Current status and contemporary approaches to the discovery of antitumor agents from higher plants
- PMID: 30633954
- PMCID: PMC6614024
- DOI: 10.1016/j.biotechadv.2019.01.004
Current status and contemporary approaches to the discovery of antitumor agents from higher plants
Abstract
Higher plant constituents have afforded clinically available anticancer drugs. These include both chemically unmodified small molecules and their synthetic derivatives currently used or those in clinical trials as antineoplastic agents, and an updated summary is provided. In addition, botanical dietary supplements, exemplified by mangosteen and noni constituents, are also covered as potential cancer chemotherapeutic agents. Approaches to metabolite purification, rapid dereplication, and biological evaluation including analytical hyphenated techniques, molecular networking, and advanced cellular and animal models are discussed. Further, enhanced and targeted drug delivery systems for phytochemicals, including micelles, nanoparticles and antibody drug conjugates (ADCs) are described herein.
Keywords: 2D and 3D cell cultures; Antibody-drug conjugates (ADCs).; Botanical dietary supplements; Cancer chemotherapeutic agents; Dereplication analytical methods; Micelles; Molecular networking; Nanoparticles; Plant natural products.
Copyright © 2019 Elsevier Inc. All rights reserved.
Figures










Similar articles
-
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Review.
-
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles.Int J Pharm. 2021 Jan 5;592:120082. doi: 10.1016/j.ijpharm.2020.120082. Epub 2020 Nov 12. Int J Pharm. 2021. PMID: 33188892 Review.
-
Natural Product Based Antibody Drug Conjugates: Clinical Status as of November 9, 2020.J Nat Prod. 2021 Mar 26;84(3):917-931. doi: 10.1021/acs.jnatprod.1c00065. Epub 2021 Feb 26. J Nat Prod. 2021. PMID: 33635651 Review.
-
Benefits and challenges of antibody drug conjugates as novel form of chemotherapy.J Control Release. 2022 Jan;341:555-565. doi: 10.1016/j.jconrel.2021.12.013. Epub 2021 Dec 11. J Control Release. 2022. PMID: 34906604 Review.
-
Immunoconjugates for Cancer Targeting: A Review of Antibody-Drug Conjugates and Antibody-Functionalized Nanoparticles.Curr Med Chem. 2021;28(13):2485-2520. doi: 10.2174/0929867327666200525161359. Curr Med Chem. 2021. PMID: 32484100 Review.
Cited by
-
Update on Phytochemical and Biological Studies on Rocaglate Derivatives from Aglaia Species.Planta Med. 2021 Oct;87(12-13):937-948. doi: 10.1055/a-1401-9562. Epub 2021 Mar 30. Planta Med. 2021. PMID: 33784769 Free PMC article. Review.
-
Multiple Myeloma Inhibitory Activity of Plant Natural Products.Cancers (Basel). 2021 May 29;13(11):2678. doi: 10.3390/cancers13112678. Cancers (Basel). 2021. PMID: 34072312 Free PMC article. Review.
-
Vincamine, from an antioxidant and a cerebral vasodilator to its anticancer potential.Bioorg Med Chem. 2023 Sep 7;92:117439. doi: 10.1016/j.bmc.2023.117439. Epub 2023 Aug 9. Bioorg Med Chem. 2023. PMID: 37579526 Free PMC article. Review.
-
Phenolic compounds of Theobroma cacao L. show potential against dengue RdRp protease enzyme inhibition by In-silico docking, DFT study, MD simulation and MMGBSA calculation.PLoS One. 2024 Mar 14;19(3):e0299238. doi: 10.1371/journal.pone.0299238. eCollection 2024. PLoS One. 2024. PMID: 38483871 Free PMC article.
-
Identification of ACHE as the hub gene targeting solasonine associated with non-small cell lung cancer (NSCLC) using integrated bioinformatics analysis.PeerJ. 2023 Oct 10;11:e16195. doi: 10.7717/peerj.16195. eCollection 2023. PeerJ. 2023. PMID: 37842037 Free PMC article.
References
-
- Abou Assi R., Darwis Y, Abdulbaqi IM, Khan AA, Vuanghao L, Laghari MH, 2017. Morinda citrifolia (noni): a comprehensive review on its industrial uses, pharmacological activities, and clinical trials. Arabian J. Chem 10, 691–707.
-
- Aisha AFA, Abdulmajid AMS, Ismail Z, Alrokayan SA, Abu-Salah KM, 2015. Development of polymeric nanoparticles of Garcinia mangostana xanthones in eudragit RL100/RS100 for anti-colon cancer drug delivery. J. Nanomater 2015, 701979.
-
- Alexis F, Rhee J-W, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC, 2008. New frontiers in nanotechnology for cancer treatment. Urol. Oncol.: Semin. Orig. Invest 26, 74–85. - PubMed
-
- Allard P-M, Peresse T, Bisson J, Gindro K, Marcourt L, Pham VC, Roussi F, Litaudon M, Wolfender J-L, 2016. Integration of molecular networking and in-silico MS/MS fragmentation for natural products dereplication. Anal. Chem 88, 3317–3323. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources